Back to BlackRock, Inc. BlackRock, Inc.

DAWNDAWN
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in DAY ONE BIOPHARMACEUTICALS I

BlackRock, Inc. previously held 0 shares of DAWN (DAY ONE BIOPHARMACEUTICALS I), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$65.6M

Total Shares Change

-4.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$21.45
0
2026-Q1
Decreased
7M
-20.3%
$151M0.0%$10.03
0
2025-Q4
Decreased
8.8M
-1.8%
$82.4M0.0%$9.18
0
2025-Q3
Decreased
9M
-8.4%
$63.5M0.0%$6.99
0
2025-Q2
Increased
9.8M
+45.5%
$63.9M0.0%$6.47
40
2025-Q1
Increased
6.8M
+9.8%
$53.6M0.0%$8.07
32
2024-Q4
Increased
6.2M
+30.7%
$78M0.0%$12.58
38
2024-Q3
First report
4.7M
-
$65.6M0.0%$14.16
0

Other major holders of DAWN: FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used